Acute coronary syndromes (ACS) are prevalent, portend a poor prognosis and represent the most threatening manifestation of coronary artery disease. While very little doubt exists about the clinical benefit of restoring culprit vessels' patency in patients admitted for ACS, the risk stratification and individual treatment strategy in these complex scenarios is not always straight forward. This is because the extension of myocardial damage and left ventricle recovery are difficult to predict, and a sizable proportion of patients admitted for ACS have bystander multivessel disease. This review summarizes available literature on the adjuvant role of invasive coronary physiology indices in guiding treatment and providing further risk stratification in patients suffering from ACS.
Yoshinobu Onuma, Takashi Muramatsu, Chrysafios Girasis, Neville Kukreja, Héctor M. García‐García, Joost Daemen, Nieves Gonzalo, Nicolò Piazza, Jannet Einthoven, Ron van Domburg, Patrick W. Serruys
Usman Baber, Gregg W. Stone, Giora Weisz, Pedro R. Moreno, George Dangas, Akiko Maehara, Gary S. Mintz, Ecaterina Cristea, Martin Fahy, Ke Xu, Alexandra J. Lansky, Bertil Wennerblom, Detlef G. Mathey, Barry Templin, Zhen Zhang, Patrick W. Serruys, Roxana Mehran
Mineok Chang, Cheol Whan Lee, Jung‐Min Ahn, Rafael Cavalcante, Yohei Sotomi, Yoshinobu Onuma, Minkyu Han, Duk‐Woo Park, Soo‐Jin Kang, Seung‐Whan Lee, Young‐Hak Kim, Seong‐Wook Park, Patrick W. Serruys, Seung‐Jung Park
Discussion(0)
No comments yet. Be the first to comment.